Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Anastasios Georgiadis is active.

Publication


Featured researches published by Anastasios Georgiadis.


Nature Biotechnology | 2013

Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina

Anai Gonzalez-Cordero; Emma L. West; Rachael A. Pearson; Yanai Duran; Livia S. Carvalho; Colin Chu; Arifa Naeem; Samuel J.I. Blackford; Anastasios Georgiadis; Jorn Lakowski; Mike Hubank; Alexander J. Smith; James W. Bainbridge; Jane C. Sowden; Robin R. Ali

Irreversible blindness caused by loss of photoreceptors may be amenable to cell therapy. We previously demonstrated retinal repair1 and restoration of vision through transplantation of photoreceptor precursors obtained from post-natal retinas into visually impaired adult mice2,3. Considerable progress has been made in differentiating embryonic stem cells (ESCs) in vitro toward photoreceptor lineages4-6. However, the capability of ESC-derived photoreceptors to integrate after transplantation has not been demonstrated unequivocally. Here, to isolate photoreceptor precursors fit for transplantation, we adapted a recently reported three-dimensional (3D) differentiation protocol that generates neuroretina from mouse ESCs6. We show that Rhop.GFP-selected rod precursors derived by this protocol integrate within degenerate retinae of adult mice and mature into outer segment–bearing photoreceptors. Notably, ESC-derived precursors at a developmental stage similar to postnatal days 4-8 integrate more efficiently than cells at other stages. This study shows conclusively that ESCs can provide a source of photoreceptors for retinal cell transplantation.


Molecular and Cellular Biology | 2006

Regulation of PCNA and Cyclin D1 Expression and Epithelial Morphogenesis by the ZO-1-Regulated Transcription Factor ZONAB/DbpA

Tony Sourisseau; Anastasios Georgiadis; Anna Tsapara; Robin R. Ali; Richard G. Pestell; Karl Matter; Maria S. Balda

ABSTRACT The tight junction protein ZO-1 inhibits G1/S-phase transition by cytoplasmic sequestration of a complex formed by CDK4 and the transcription factor ZONAB. Canine ZONAB is the homologue of human DbpA, an E2F target gene that is overexpressed in different carcinomas. Since the ZONAB target genes that are involved in G1/S-phase transition are unknown, we employed the mammary epithelial cell line MCF-10A and cDNA arrays to screen for such genes. We identified genes encoding cell cycle and replication proteins whose expression was altered due to increased ZONAB expression. For proliferative cell nuclear antigen and cyclin D1 genes, we show that increased mRNA levels resulted in increased protein levels and we identified ZONAB-responsive elements in their promoters by using different approaches, including chromatin immunoprecipitation assays. RNA interference and overexpression of ZONAB affected the proliferation of both MCF-10A and MDCK cells as well as the differentiation of MDCK cells into polarized cysts in three-dimensional cultures. These results indicate that ZONAB regulates the transcription of genes that are important for G1/S-phase progression and links tight junctions to the transcriptional control of key cell cycle regulators and epithelial cell differentiation.


Journal of Gene Medicine | 2003

Long-term evaluation of retinal function in Prph2Rd2/Rd2 mice following AAV-mediated gene replacement therapy

Frank C. Schlichtenbrede; Lyndon da Cruz; C Stephens; Alexander J. Smith; Anastasios Georgiadis; Adrian J. Thrasher; James W. Bainbridge; Mathias W. Seeliger; Robin R. Ali

Prph2Rd2/Rd2 mice have a retinal degeneration due to a null mutation for the Prph2 gene which encodes a photoreceptor‐specific glycoprotein, peripherin2, essential for outer‐segment formation. We have previously shown improvement of photoreceptor function at a single time point following AAV‐mediated gene replacement therapy. Here we quantify the functional rescue over a 15‐week time course and present a detailed analysis of the improvement in retinal function.


Nature Communications | 2016

Donor and host photoreceptors engage in material transfer following transplantation of post-mitotic photoreceptor precursors

Rachael A. Pearson; Anai Gonzalez-Cordero; Emma L. West; Joana Ribeiro; Nozie D. Aghaizu; Debbie Goh; Robert D. Sampson; Anastasios Georgiadis; P. V. Waldron; Yanai Duran; Arifa Naeem; Magdalena Kloc; Enrico Cristante; Kamil Kruczek; Katherine Warre-Cornish; Jane C. Sowden; Alexander J. Smith; Robin R. Ali

Photoreceptor replacement by transplantation is proposed as a treatment for blindness. Transplantation of healthy photoreceptor precursor cells into diseased murine eyes leads to the presence of functional photoreceptors within host retinae that express an array of donor-specific proteins. The resulting improvement in visual function was understood to be due to donor cells integrating within host retinae. Here, however, we show that while integration occurs the majority of donor-reporter-labelled cells in the host arises as a result of material transfer between donor and host photoreceptors. Material transfer does not involve permanent donor–host nuclear or cell–cell fusion, or the uptake of free protein or nucleic acid from the extracellular environment. Instead, RNA and/or protein are exchanged between donor and host cells in vivo. These data require a re-evaluation of the mechanisms underlying rescue by photoreceptor transplantation and raise the possibility of material transfer as a strategy for the treatment of retinal disorders.


Gene Therapy | 2003

Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.

James W. Bainbridge; A Mistry; Frank C. Schlichtenbrede; Alexander J. Smith; Cathryn Broderick; M de Alwis; Anastasios Georgiadis; P Taylor; M Squires; C Sethi; David G. Charteris; Aj Thrasher; D Sargan; Robin R. Ali

Recombinant adeno-associated virus (rAAV) vectors are attractive candidates for the treatment of inherited and acquired retinal disease. Although rAAV vectors are well characterized in rodent models, a prerequisite to their clinical application in human patients is the thorough evaluation of their efficacy and safety in intermediate animal models. In this study, we describe rAAV-2-mediated expression of GFP reporter gene in retinal cells following local vector delivery in dogs. Subretinal delivery of rAAV.CMV.GFP was performed unilaterally in eight normal dogs from 6 weeks of age. The area of retinal transduction was maximized by the optimization of surgical techniques for subretinal vector delivery by pars-plana vitrectomy and the use of fine-gauge subretinal cannulae to create multiple retinotomies. rAAV-2 vectors mediated efficient stable reporter gene expression in photoreceptors and retinal pigment epithelial cells. We found efficient transduction of cone photoreceptors in addition to rods in both the canine retina and after subretinal vector delivery in another intermediate animal model, the feline retina. GFP expression in dogs was confined to the area of the retinal bleb and was sustained in cells at this site for at least 18 months. Electroretinography demonstrated a modest reduction in global rod-mediated retinal function following subretinal delivery of rAAV.CMV.GFP. Three of the eight animals developed delayed-onset intraocular inflammation, in two cases associated with a serum antibody response to GFP protein. We conclude that rAAV-2 vectors mediate efficient sustained transgene expression in rod and cone photoreceptors following subretinal delivery in this intermediate animal model. The possibility of adverse effects including intraocular immune responses and reduced retinal function requires further investigation prior to clinical applications in patients.


PLOS ONE | 2010

The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice.

Anastasios Georgiadis; M. Tschernutter; James W. Bainbridge; Kamaljit S. Balaggan; F. Mowat; Emma L. West; Peter M.G. Munro; Adrian J. Thrasher; Karl Matter; Maria S. Balda; Robin R. Ali

Cell-cell adhesion regulates the development and function of epithelia by providing mechanical support and by guiding cell proliferation and differentiation. The tight junction (TJ) protein zonula occludens (ZO)-1 regulates cell proliferation and gene expression by inhibiting the activity of the Y-box transcription factor ZONAB in cultured epithelial cells. We investigated the role of this TJ-associated signalling pathway in the retinal pigment epithelium (RPE) in vivo by lentivirally-mediated overexpression of ZONAB, and knockdown of its cellular inhibitor ZO-1. Both overexpression of ZONAB or knockdown of ZO-1 resulted in increased RPE proliferation, and induced ultrastructural changes of an epithelial-mesenchymal transition (EMT)-like phenotype. Electron microscopy analysis revealed that transduced RPE monolayers were disorganised with increased pyknosis and monolayer breaks, correlating with increased expression of several EMT markers. Moreover, fluorescein angiography analysis demonstrated that the increased proliferation and EMT-like phenotype induced by overexpression of ZONAB or downregulation of ZO-1 resulted in RPE dysfunction. These findings demonstrate that ZO-1 and ZONAB are critical for differentiation and homeostasis of the RPE monolayer and may be involved in RPE disorders such as proliferative vitroretinopathy and atrophic age-related macular degeneration.


Gene Therapy | 2010

AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins

Anastasios Georgiadis; M. Tschernutter; James W. Bainbridge; Scott J. Robbie; Jenny McIntosh; Amit C. Nathwani; Alexander J. Smith; Robin R. Ali

Gene therapy for inherited retinal degeneration in which expression of a mutant allele has a gain-of-function effect on photoreceptor cells is likely to depend on efficient silencing of the mutated allele. Peripherin-2 (Prph2, also known as peripherin/RDS) is an abundantly expressed photoreceptor-specific gene. In humans, gain-of-function mutations in PRPH2 result in both autosomal dominant retinitis pigmentosa and dominant maculopathies. Gene-silencing strategies for these conditions include RNA interference by short hairpin RNAs (shRNAs). Recent evidence suggests that microRNA (miRNA)-based hairpins may offer a safer and more effective alternative. In this study, we used for the first time a virally transferred miRNA-based hairpin to silence Prph2 in the murine retina. The results show that an miRNA-based shRNA can efficiently and specifically silence Prph2 in vivo as early as 3 weeks after AAV2/8-mediated subretinal delivery, leading to a nearly 50% reduction of photoreceptor cells after 5 weeks. We conclude that miRNA-based hairpins can achieve rapid and robust gene silencing after efficient vector-mediated delivery to the retina. The rationale of using an miRNA-based template to improve the silencing efficiency of a hairpin may prove valuable for allele-specific silencing in which the choice for an RNAi target is limited and offers an alternative therapeutic strategy for the treatment of dominant retinopathies.


Gene Therapy | 2016

Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.

Anastasios Georgiadis; Yanai Duran; Joana Ribeiro; Laura Abelleira-Hervas; Scott J. Robbie; B Sünkel-Laing; S Fourali; Anai Gonzalez-Cordero; Enrico Cristante; Michel Michaelides; James W. Bainbridge; Alexander J. Smith; Robin R. Ali

Leber congenital amaurosis is a group of inherited retinal dystrophies that cause severe sight impairment in childhood; RPE65-deficiency causes impaired rod photoreceptor function from birth and progressive impairment of cone photoreceptor function associated with retinal degeneration. In animal models of RPE65 deficiency, subretinal injection of recombinant adeno-associated virus (AAV) 2/2 vectors carrying RPE65 cDNA improves rod photoreceptor function, and intervention at an early stage of disease provides sustained benefit by protecting cone photoreceptors against retinal degeneration. In affected humans, administration of these vectors has resulted to date in relatively modest improvements in photoreceptor function, even when retinal degeneration is comparatively mild, and the duration of benefit is limited by progressive retinal degeneration. We conclude that the demand for RPE65 in humans is not fully met by current vectors, and predict that a more powerful vector will provide more durable benefit. With this aim we have modified the original AAV2/2 vector to generate AAV2/5-OPTIRPE65. The new configuration consists of an AAV vector serotype 5 carrying an optimized hRPE65 promoter and a codon-optimized hRPE65 gene. In mice, AAV2/5-OPTIRPE65 is at least 300-fold more potent than our original AAV2/2 vector.


Stem cell reports | 2017

Differentiation and Transplantation of Embryonic Stem Cell-Derived Cone Photoreceptors into a Mouse Model of End-Stage Retinal Degeneration

Kamil Kruczek; Anai Gonzalez-Cordero; Debbie Goh; Arifa Naeem; Mindaugas Jonikas; Samuel J.I. Blackford; Magdalena Kloc; Yanai Duran; Anastasios Georgiadis; Robert D. Sampson; Ryea N. Maswood; Alexander J. Smith; Sarah Decembrini; Yvan Arsenijevic; Jane C. Sowden; Rachael A. Pearson; Emma L. West; Robin R. Ali

Summary The loss of cone photoreceptors that mediate daylight vision represents a leading cause of blindness, for which cell replacement by transplantation offers a promising treatment strategy. Here, we characterize cone differentiation in retinas derived from mouse embryonic stem cells (mESCs). Similar to in vivo development, a temporal pattern of progenitor marker expression is followed by the differentiation of early thyroid hormone receptor β2-positive precursors and, subsequently, photoreceptors exhibiting cone-specific phototransduction-related proteins. We establish that stage-specific inhibition of the Notch pathway increases cone cell differentiation, while retinoic acid signaling regulates cone maturation, comparable with their actions in vivo. MESC-derived cones can be isolated in large numbers and transplanted into adult mouse eyes, showing capacity to survive and mature in the subretinal space of Aipl1−/− mice, a model of end-stage retinal degeneration. Together, this work identifies a robust, renewable cell source for cone replacement by purified cell suspension transplantation.


Gene Therapy | 2012

Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53 -deficient mice

Kamaljit S. Balaggan; Yanai Duran; Anastasios Georgiadis; C Thaung; Susie E. Barker; Prateek K. Buch; Angus MacNeil; Scott J. Robbie; James W. Bainbridge; Alexander J. Smith; Robin R. Ali

Insertional mutagenesis following gene therapy with gammaretroviral vectors can cause the development of lymphoproliferation in children with X-linked severe combined immunodeficiency. In experimental studies, recombinant adeno-associated virus (rAAV) vectors have also been reported to increase susceptibility to carcinogenesis. The possibility of vector-induced transformation in quiescent ocular cells is probably significantly lower than in mitotically active cells, but given the increasing number of clinical applications of rAAV and lentiviral vectors for ocular disease, a specific assessment of their oncogenic potential in the eye is important. In this study, we investigated the effect of rAAV2/2 and integrating HIV-1 vectors upon the incidence of ocular neoplasia in p53 tumour-suppressor gene-knockout (p53−/−) mice, which are highly susceptible to intraocular malignant transformation. Subretinal injections of high titre rAAV2/2 or integrating HIV-1 vectors induced no tumours in p53−/− or p53+/− animals, nor significantly affected their natural longevity. We conclude that any insertional events arising from subretinal delivery of these vectors appear insufficient to cause intraocular malignancy, even in highly susceptible animals. These findings support the continued development of these vectors for ocular applications.

Collaboration


Dive into the Anastasios Georgiadis's collaboration.

Top Co-Authors

Avatar

Robin R. Ali

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

Alexander J. Smith

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

James W. Bainbridge

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

Yanai Duran

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

Rachael A. Pearson

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

Scott J. Robbie

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

Emma L. West

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

M. Tschernutter

UCL Institute of Ophthalmology

View shared research outputs
Top Co-Authors

Avatar

Jane C. Sowden

UCL Institute of Child Health

View shared research outputs
Top Co-Authors

Avatar

Anai Gonzalez-Cordero

UCL Institute of Ophthalmology

View shared research outputs
Researchain Logo
Decentralizing Knowledge